DOI:
10.1055/s-00050348
Indian Journal of Medical and Paediatric Oncology
LinksClose Window
References
Swain SM, Kim SB, Cortés J, Ro J, Semiglazov V, Campone M. et al.
Pertuzumab, trastuzumab, and docetaxel for HER2-positive metastatic breast cancer (CLEOPATRA): end-of-study results from a double-blind, randomised, placebo-controlled, phase 3 study.
Lancet Oncol 2020;
21: 519-30
Access:
Access:
We do not assume any responsibility for the contents of the web pages of other providers.